Schizophrenia News and Research

Latest Schizophrenia News and Research

Uncovering the science behind generations of mental illness

Sometimes the most interesting way to digest scientific information is within the context of personal experiences. Likewise, the story of someone's personal journey or struggle can take on broader significance when melded with the insights of scientific knowledge.

14 Mar 2012

Recent studies aim to find better treatment for children with speech problems

Recent studies by a UT Dallas researcher aim at finding better ways to diagnose young children with language impairments.

13 Mar 2012

Reviva to initiate enrollment in RP503 phase 2 study for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of patients in its phase 2 clinical study of RP503 for schizophrenia and schizoaffective disorder.

13 Mar 2012

Allon advances into second phase of work in preclinical PD model

Allon Therapeutics Inc. announced today the completion of its first phase of work in a preclinical Parkinson's disease model and advancement into the second phase of work. Both phases are funded by The Michael J. Fox Foundation for Parkinson's Research and carried out by Prof. Marie-Francoise Chesselet's lab at the University of California Los Angeles.

12 Mar 2012

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.

12 Mar 2012

LSD for alcohol addiction: Study

Hallucinogenic drug LSD (lysergic acid diethylamide) could help alcoholics give up drinking, according to an analysis of studies performed in the 1960s. A study, presented in the Journal of Psychopharmacology, looked at data from six trials and more than 500 patients. It said there was a “significant beneficial effect” on alcohol abuse, which lasted several months after the drug was taken.

12 Mar 2012

CB2 receptor involved in regulating impulsive behaviour

A new study lead by the Neuroscience Institute of Alicante reveals how manipulating the endocannabinoid system can modulate high levels of impulsivity. This is the main problem in psychiatric illnesses such a schizophrenia, bipolar disorder and substance abuse.

8 Mar 2012

Loss of glutamate receptor linked to negative effects of chronic stress

Chronic stress has a more powerful effect on the brain during adolescence than in adulthood and now there's proof at the molecular level, according to findings published in Neuron by University at Buffalo researchers.

8 Mar 2012

Researchers document unknown biological mechanism in the blood-brain barrier

Researchers at the University of Copenhagen have documented a previously unknown biological mechanism in the brain's most important line of defence: the blood-brain barrier. Scientists now know that the barrier helps maintain a delicate balance of glutamate, a vital signal compound in the brain.

8 Mar 2012

BioLineRx receives European patent for BL-1020 to treat schizophrenia

BioLineRx, a biopharmaceutical development company, announced today that a European patent has been granted claiming BL-1020's composition and its use for the treatment of schizophrenia.

8 Mar 2012

New research provides explanation for some of autism's mysteries

New research from Carnegie Mellon University's Marcel Just provides an explanation for some of autism's mysteries - from social and communication disorders to restricted interests - and gives scientists clear targets for developing intervention and treatment therapies.

7 Mar 2012

People with schizophrenia benefit from new evidence-based clinical program

People with schizophrenia report improved functioning after participating in a new, evidence-based clinical program, according to results announced today from a six-month pilot.

7 Mar 2012

Almost 70% of young adults with Asperger syndrome have suffered from depression

Given that almost 70% of young adults with Asperger syndrome have suffered from depression, it is vital that psychiatric care staff are aware of this so that patients are given the right treatment, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

6 Mar 2012

Study shows how new information is encoded into prefrontal cortex

The brain has a remarkable ability to learn new cognitive tasks while maintaining previously acquired knowledge about various functions necessary for everyday life. But exactly how new information is incorporated into brain systems that control cognitive functions has remained a mystery.

6 Mar 2012

ACADIA, Allergan extend drug discovery collaboration

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has extended its drug discovery and development collaboration with Allergan, Inc..

5 Mar 2012

BioLineRx granted Israeli approval for BL-7040 Phase II clinical trial for IBD

BioLineRx a biopharmaceutical development company, announced today that it has received approval from the Israeli Ministry of Health for commencing a Phase II clinical trial of BL-7040, an orally available molecule for treating Inflammatory Bowel Disease (IBD).

5 Mar 2012

Viewpoints: Ryan and Medicare; Va. ultrasound bill 'overreaches'?; NEJM on patient-centered care

Over the past year, an entitlement revolution has taken place on Capitol Hill. ... The revolution involves Medicare, the health-care program for the elderly and the single biggest cause of America's looming debt crisis. Reform of Medicare would be achieved by a policy known as "premium support." It would bring consumer choice and spending restraint to the beleaguered program.

1 Mar 2012

Similar mechanisms drive changes in puberty

It's one of life's special moments: a child finds a fat caterpillar, puts it in a jar with a twig and a few leaves, and awakens one day to find the caterpillar has disappeared and an elegant but apparently lifeless case now hangs from the twig.

1 Mar 2012

Digital exercises improve brain function, behavior in people with schizophrenia

People with schizophrenia who completed 80 hours of intensive, computerized cognitive training exercises were better able to perform complex tasks that required them to distinguish their internal thoughts from reality.

1 Mar 2012

MU researcher to improve current rehabilitation strategies for amputees

When a limb is lost or absent from birth, patients have different strategies that can be used for rehabilitation. However, this rehabilitation can be mentally exhausting and extremely painful in some cases, and scientists are looking for ways to improve the rehabilitation experience.

1 Mar 2012